The Open Targets Blog
OCTOBER 24, 2023
Amir Feizi is the Director of Bioinformatics at OMass Therapeutics, a spinout from Professor Dame Carol Robinson’s Laboratory at the University of Oxford. Their work was recently published in Bioinformatics. We chat with him about otargen, and the importance of sharing open-source resources within the bioinformatics community.
Elrig
APRIL 29, 2024
Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Bioinformatics is all about bringing together different areas of knowledge. big pharma or startups/spin off? What pro/cons?
Drug Discovery World
NOVEMBER 15, 2022
If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . “We Cell-free systems for drug design and manufacturing .
Expert insights. Personalized for you.
64 
Let's personalize your content